Kuros Biosciences Ltd.
Healthcare · GBP · SIX
Price
£21.32
Cap
£275.09M
Earnings
—
30d Trend
-2.7%
52% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 39×Macro 0.99 (−1%)=39
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Limited short-term thesis
BRAIN47'S ASSESSMENT
I rate Kuros Biosciences Ltd. at 39/100 — a WEAK reading on the Brain47 Signal. The strongest factor is quality at 62/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
+1.5%
3 MONTHS
-21.2%
12 MONTHS
—
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Limited short-term thesis. Quality (62) and Technical (42) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 52%. I classify this as a speculative position — elevated volatility at 52% and smaller market cap define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.